Home > Healthcare > Medical Devices > Diagnostic Devices > thyroid function testing market
Get a free sample of Thyroid Function Testing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Thyroid Function Testing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Public health initiatives and awareness campaigns promote early disease detection through screening programs, including thyroid function testing. These programs target high-risk populations such as pregnant women, those with family history, or individuals exposed to environmental factors affecting thyroid function. For instance, the US preventive services task force (USPSTF) advises screening for symptomatic "overt" hypothyroidism and hyperthyroidism, targeting individuals with persistent abnormal TSH and T4 levels, along with clear clinical signs. This aims to diagnose thyroid dysfunction in symptomatic individuals rather than asymptomatic ones.
The reagents and kits segment in the thyroid function testing industry will reach USD 3.8 billion by 2032 due to their pivotal role as essential components in diagnostic procedures, ensuring accurate and reliable test results.
Thyroid function testing industry size was valued USD 3.9 billion in 2023 and will demonstrate a 6.1% CAGR between 2024 and 2032, attributed to increasing incidence of thyroid disorders, advancements in diagnostic technologies, and the rise in healthcare expenditure.
North America thyroid function testing industry recorded 40.4% share in 2023, propelled by factors, such as advanced healthcare infrastructure, widespread awareness about thyroid disorders, and a large patient pool.
Some of the key market players are Abbott Laboratories, bioMerieux S.A., Bio-Rad Laboratories, Inc., Cipla Limited, Danaher Corporation, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Quidelortho Corporation, Randox Laboratories Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., among others.